These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
No
fee required
|
|
o
|
Fee
computed on table below per Exchange Act Rules 14a- 6(i)(1) and
0-11.
|
|
(1)Title
of each class of securities to which transaction
applies:
|
|
|
(2)Aggregate
number of securities to which transaction applies:
|
|
|
(3)Per
unit price or other underlying value of transaction computed pursuant to
Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is
calculated and state how it was determined):
|
|
|
(4)Proposed
maximum aggregate value of transaction:
|
|
|
(5)Total
fee paid:
|
|
|
o
|
Fee
paid previously with preliminary materials.
|
|
o
|
Check
box if any part of the fee is offset as provided by Exchange Act Rule
0-11(a)(2) and identify the filing for which the offsetting fee was paid
previously. Identify the previous filing by registration statement number,
or the Form or Schedule and the date of its filing.
|
|
(1)
Amount Previously Paid:
|
|
|
(2)
Form, Schedule or Registration Statement No.:
|
|
|
(3)
Filing Party:
|
|
|
(4)
Date Filed:
|
|

| February 24, 2010 |
|
Sincerely,
![]() Thomas
L. Massie
President
and Chief Executive Officer
|
|
1.
|
To
elect two directors;
|
|
2.
|
To
amend the Bridgeline Software, Inc. Amended and Restated Stock Incentive
Plan to increase the number of shares of Common Stock available for
issuance upon exercise of options granted under the Plan from 2,000,000
shares to 2,400,000 shares;
|
|
3.
|
To
ratify the appointment of UHY LLP as the Company’s
independent registered public accounting firm for its fiscal year ending
September 30, 2010; and
|
|
4.
|
To
transact such other business as may properly come before the
Meeting.
|
|
By
Order of the Board of Directors
![]() Assistant
Secretary
February
24, 2010
|
|
1.
|
Consider
and act upon a motion to elect two
directors;
|
|
2.
|
Consider
and act upon a motion to amend the Bridgeline Software, Inc. Amended and
Restated Stock Incentive Plan to increase the number of shares of Common
Stock available for issuance upon exercise of options granted under the
Plan from 2,000,000 shares to 2,400,000
shares;
|
|
3.
|
Consider
and act upon a motion to ratify the appointment of UHY LLP as the
Company’s independent registered public accounting firm for its fiscal
year ending September 30, 2010; and
|
|
4.
|
Transact
such other business as may properly come before the Meeting. In the
absence of direction, the proxy will be voted in favor of management’s
proposals.
|
|
Name
|
Age
|
Position
with the Company
|
Director
Since
|
|
|
Nominees
for Director for Terms Expiring in 2013
|
||||
|
Kenneth
Galaznik*
|
58
|
Director,
Chair of the Audit Committee
|
2006
|
|
|
Scott
Landers*
|
39
|
Director
|
2010
|
|
|
Directors
with Terms Expiring in 2012
|
||||
|
William
Coldrick*
|
67
|
Director,
Chair of the Nominating and Corporate Governance Committee, Member of the
Compensation Committee and Audit Committee
|
2000
|
|
|
Thomas
Massie
|
48
|
Chairman
of the Board of Directors, President and Chief Executive
Officer
|
2000
|
|
|
Directors
with Terms Expiring in 2011
|
||||
|
Robert
Hegarty*
|
46
|
Director,
Chair of the Compensation Committee, Member of the Nominating and
Corporate Governance Committee
|
2006
|
|
|
John
Cavalier*
|
70
|
Director,
Member of the Audit Committee, the Compensation Committee and the
Nominating and Corporate Governance Committee
|
2007
|
|
|
Name
|
Age
|
Position
with the Company
|
|
Ronald
M. Levenson
|
54
|
Executive
Vice President and Chief Financial Officer
|
|
Brett
Zucker
|
37
|
Executive
Vice President and Chief Technology
Officer
|
|
Name
and Address
|
Number
of Shares Owned
|
Percent
of Shares Outstanding
|
|
|
P.A.W.
Capital Corp
Peter
A. Wright
4
Greenwich Office Park, 3rd Floor
Greenwich,
CT 06831
|
630,000
|
(1)
|
5.63%
|
|
Erez
Katz
|
1,077,422
|
(2)
|
9.62%
|
|
Thomas
Massie
|
903,111
|
(3)
|
8.03%
|
|
Tim
Higgins
|
266,449
|
2.38%
|
|
|
Tony
Pietrocola
|
236,956
|
(4)
|
2.12%
|
|
Michael
Matteo
|
168,673
|
(5)
|
1.50%
|
|
Brett
Zucker
|
146,631
|
(6)
|
1.30%
|
|
William
Matteson
|
137,000
|
(7)
|
1.22%
|
|
John
Cavalier
|
99,999
|
(8)
|
*
|
|
William
Coldrick
|
85,888
|
(9)
|
*
|
|
Robert
Hegarty
|
26,999
|
(10)
|
*
|
|
Kenneth
Galaznik
|
14,999
|
(11)
|
*
|
|
Scott
Landers
|
—
|
—
|
|
|
Ronald
M. Levenson
|
—
|
—
|
|
|
All
current executive officers, directors and certain members of senior
management who beneficially own more than 1% of the outstanding shares of
common stock as a group (13 persons)
|
3,164,127
|
(12)
|
27.72%
|
|
(1)
|
Based
on the Schedule 13G filed by the holder on January 15,
2010.
|
|
(2)
|
Includes
9,999 shares of common stock subject to currently exercisable options
(includes options that will become exercisable within 60 days of January
15, 2010).
|
|
(3)
|
Includes
49,444 shares of common stock subject to currently exercisable options
(includes options that will become exercisable within 60 days of January
15, 2010). Also includes 10,000 shares of common stock issuable upon
exercise of a warrant.
|
|
(4)
|
Includes
5,000 shares of common stock subject to currently exercisable options
(includes options that will become exercisable within 60 days of January
15, 2010).
|
|
(5)
|
Includes
34,015 shares of common stock subject to currently exercisable options
(includes options that will become exercisable within 60 days of January
15, 2010).
|
|
(6)
|
Includes
67,128 shares of common stock subject to currently exercisable options
(includes options that will become exercisable within 60 days of January
15, 2010).
|
|
(7)
|
Includes
6,000 shares of common stock subject to currently exercisable options
(includes options that will become exercisable within 60 days of January
15, 2010).
|
|
(8)
|
Includes
6,666 shares of common stock subject to currently exercisable options
(includes options that will become exercisable within 60 days of January
15, 2010).
|
|
(9)
|
Includes
12,221 shares of common stock subject to currently exercisable options
(includes options that will become exercisable within 60 days of January
15, 2010).
|
|
(10)
|
Includes
2,000 shares of common stock beneficially owned by Mr. Hegarty’s
spouse. Includes 14,999 shares of common stock subject to currently
exercisable options (includes options that will become exercisable within
60 days of January 15, 2010).
|
|
(11)
|
Includes
14,999 shares of common stock subject to currently exercisable options
(includes options that will become exercisable within 60 days of January
15, 2010).
|
|
(12)
|
Includes
220,471 shares of common stock subject to currently exercisable options
(includes options that will become exercisable within 60 days of January
15, 2010). Also includes 10,000 shares of common stock issuable upon
exercise of a warrant.
|
|
Name
and Principal Position
|
Fiscal
Year
End
|
Salary
|
Bonus
|
Option
Awards (1)
|
All
Other
Compensation
|
Total
|
|
Thomas
Massie
|
2009
|
$325,000
|
$51,563
|
$73,676
|
$24,242
(2)
|
$474,481
|
|
Chief
Executive Officer and Director
|
2008
|
$225,000
|
$38,750
|
$161,800
|
$24,242
(2)
|
$449,792
|
|
Ronald
M. Levenson
|
2009
|
$105,721
|
$25,000
|
$17,409
|
—
|
$148,130
|
|
Executive
Vice President and Chief Financial Officer
|
2008
|
—
|
—
|
—
|
—
|
—
|
|
Brett
Zucker
|
2009
|
$178,745
|
$29,250
|
$64,576
|
—
|
$274,571
|
|
Executive
Vice President and Chief Technology Officer
|
2008
|
$175,000
|
$46,300
|
$77,200
|
—
|
$298,500
|
|
(1)
|
Amounts
in the Option Awards column do not reflect compensation actually paid to
or realized by the named executive officer. Such amounts reflect
compensation cost for fiscal years ended September 30, 2009 and 2008
calculated in accordance with SFAS 123(R), which includes the ratable
amount of expense in such years for options granted in prior
years. The assumptions used to value stock options can be found
in Note 10 to our Consolidated Financial Statements for the year ended
September 30, 2009 contained in our annual report on Form
10-K. The calculations above, however, exclude assumptions with
respect to forfeitures. A forfeiture rate was used in the
expense calculation in the consolidated financial
statements.
|
|
(2)
|
Represents
life insurance premiums.
|
|
Option
Awards
|
||||
|
Name
|
Number
of Securities
Underlying
Unexercised
Options
(#) Exercisable
|
Number
of Securities
Underlying
Unexercised
Options
(#) Unexercisable
|
Option
Exercise Price
|
Option
Expiration Date
|
|
Thomas
Massie (1)
|
6,667
|
$0.003
|
09/30/12
|
|
|
33,333
|
$0.900
|
10/09/18
|
||
|
75,000
|
$0.900
|
10/09/18
|
||
|
20,000
|
$0.900
|
10/09/18
|
||
|
Ronald
M. Levenson (2)
|
—
|
100,000
|
$1.060
|
04/13/19
|
|
Brett
Zucker (3)
|
1,820
|
$0.357
|
02/27/12
|
|
|
25,130
|
$0.900
|
10/09/18
|
||
|
25,000
|
$0.900
|
10/09/18
|
||
|
100,000
|
$0.900
|
10/09/18
|
||
|
30,000
|
$0.900
|
10/09/18
|
||
|
20,000
|
$0.900
|
10/09/18
|
||
|
(1)
|
Grants
dated: 09/30/02 for 6,667 shares; and 10/09/08 for 33,333, 75,000 and
20,000 shares. Shares vest in equal installments upon the anniversary date
of the grant over three years. All options, with the exception
of the option dated 09/30/02, were issued as part of the Company’s
repricing plan in October 2008.
|
|
(2)
|
Grant
dated 04/13/09 for 100,000 shares. Shares vest in equal
installments upon the anniversary date of the grant over three
years.
|
|
(3)
|
Grants
dated: 02/27/2002 for 1,820 shares; and 10/09/08 for 25,130, 25,000,
100,000, 30,000 and 20,000 shares. Shares vest in equal
installments upon the anniversary date of the grant over three
years. All options, with the exception of the option dated
02/27/02, were issued as part of the Company’s repricing plan in October
2008.
|
|
Name
|
Fees
Earned or Paid in Cash
|
Option
Awards
(1)(2)
|
All
Other
Compensation
|
Total
|
|
John
Cavalier
|
$18,000
|
$13,440
|
—
|
$31,440
|
|
William
Coldrick
|
$23,000
|
$16,580
|
—
|
$39,580
|
|
Kenneth
Galaznik
|
$26,000
|
$17,494
|
—
|
$43,494
|
|
Robert
Hegarty
|
$23,000
|
$17,494
|
—
|
$40,494
|
|
Scott
Landers (3)
|
—
|
—
|
—
|
—
|
|
(1)
|
Amounts
in the Option Awards column do not reflect compensation actually paid to
or realized by the Directors. Such amounts reflect compensation cost for
fiscal year ended September 30, 2009 calculated in accordance with SFAS
123(R), which includes the ratable amount of expense in such years for
options granted in prior years. The assumptions used to value
stock options can be found in Note 10 to our Consolidated Financial
Statements for the year ended September 30, 2009 contained in our annual
report on Form 10-K. The calculations above, however, exclude
assumptions with respect to forfeitures. A forfeiture rate was
used in the expense calculation in the consolidated financial
statements.
|
|
(2)
|
Stock
options to purchase 10,000 shares were granted on
10/27/08.
|
|
Name
|
Number of Shares
Underlying
Outstanding
Stock Options
|
|
|
John
Cavalier
|
20,000
|
|
|
William
Coldrick
|
36,667
|
|
|
Kenneth
Galaznik
|
45,000
|
|
|
Robert
Hegarty
|
45,000
|
|
|
Scott
Landers
|
—
|
|
·
|
Option Grants. Outside
directors each receive annual grants of options to purchase 10,000 shares
of our common stock at an exercise price equal to the fair market value of
the shares on the date of grant. The options shall vest over three years
in equal installments on the anniversary of grant. New directors receive
options to purchase 25,000 shares of our common stock at the then current
fair market value upon election to the
Board.
|
|
·
|
Cash Compensation. Each
outside director receives an annual retainer of $12,000 and is compensated
$1,500 for each meeting such director attends in
person.
|
|
·
|
Committee Chair Bonus.
The Chair of our Audit Committee receives an additional annual fee
of $8,000. The Chairs of our Compensation Committee and Nominating and
Corporate Governance Committee each receive an additional annual fee of
$5,000. These fees are payable in lump sums in advance. Other directors
who serve on our standing committees do not receive additional
compensation for their committee
services.
|
|
·
|
Travel Expenses. All
directors are reimbursed for their reasonable out of pocket expenses
associated with attending meetings. For domestic travel, only coach
airfare will be reimbursed; for international travel we reimburse for
business class.
|
|
Submitted
by the members of the Audit Committee:
Kenneth
Galaznik, Chairman
John
Cavalier
William
Coldrick
|
|
Type
of Service
|
Amount
of Fee for Fiscal Year Ended
|
|
|
September
30, 2009
|
September
30, 2008
|
|
|
Audit
Fees
|
$
205,663
|
$
224,277
|
|
Audit-Related
Fees
|
—
|
58,609
|
|
Tax
Fees
|
—
|
—
|
|
Total
|
$
205,663
|
$
282,886
|
|
By
Order of the Board of Directors
![]() Ronald
M. Levenson
Assistant
Secretary
February
24, 2010
|
|
A.
|
To
elect the following nominees as
directors.
|
| For | Withhold | ||
| 1. Kenneth Galaznik | r | r | |
| 2. Scott Landers | r | r |
|
B.
|
To
approve the amendment to the Bridgeline Software, Inc. Amended and
Restated Stock Incentive Plan to increase the number of shares of Common
Stock available for issuance upon exercise of options granted under the
Plan from 2,000,000 shares to 2,400,000
shares.
|
|
C.
|
To
ratify the appointment of UHY LLP as the Company’s independent auditors
for the Company’s fiscal year ending September 30,
2010.
|
|
D.
|
In
their discretion, on such other matters as may properly come before the
meeting.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|